Women’s health represents one of healthcare’s most significant unmet needs and one of its most overlooked opportunities.

For decades, sex-specific differences and women’s health conditions have received insufficient attention in research, clinical practice and investment.

That is changing.

Advances in science, technology and medicine are creating new opportunities to improve how diseases are understood, diagnosed and treated.

FemTech Capital exists to help promising innovation become better understood, better supported, better connected and better funded.

Women’s health has been overlooked for too long.

OUR MISSION

Build a healthier, more equitable future through better science, stronger companies and smarter capital.

FemTech Capital brings together the people required to move innovation from scientific possibility toward clinical, commercial and societal impact.

Founders.
Scientists.
Clinicians.
Operators.
Investors.
Industry.

One specialist ecosystem.

We focus on opportunities where

Meaningful unmet clinical need

MEETS

Emerging science and technology

MEETS

Credible commercial opportunity.

Specialist expertise is essential to identifying, evaluating and advancing these opportunities.

OUR THESIS

Opportunity begins where understanding is incomplete.

Historically under-researched and underfunded areas of healthcare can represent significant unmet clinical needs and overlooked commercial opportunities.

OUR MODEL

EDUCATION & EVIDENCE

Build understanding through science and evidence.

ECOSYSTEM

Connect multidisciplinary expertise.

ASSESSMENT

Evaluate innovation and company readiness.

DERISKING

Identify and address critical gaps.

CAPITAL CONNECTIONS

Improve connectivity with relevant capital.

VALUE CREATION

Support commercialization and growth.

OUR PRINCIPLES

EVIDENCE FIRST

Scientific credibility matters more than hype.

SPECIALIST BY DESIGN

Healthcare innovation requires expertise beyond financial analysis.

INDEPENDENCE

Commercial relationships do not determine FTC assessment outcomes.

TRANSPARENCY

Relationships, roles and relevant interests should be clearly disclosed.

REAL IMPACT

We focus on meaningful clinical, commercial and societal outcomes.

INDEPENDENCE BY DESIGN

FTC works with investors, companies, experts, sponsors and strategic partners across the ecosystem.

Commercial partnerships and sponsorships do not determine FTC assessment outcomes.

Participation in the FTC ecosystem does not constitute endorsement of a company, financial instrument or investment opportunity, nor does it confer preferential assessment or investment treatment.

LEADERSHIP

Alexandra Hirzel

Founder & CEO FemTech Capital

Entrepreneur, Investor, Venture Partner, Operating Partner and NED working across healthcare, AI and deep technology.

Alexandra Hirzel is a serial entrepreneur, investor and board director with nearly two decades of experience building, scaling and commercializing technology businesses across the United States and Europe.

Having founded, operated and exited, she brings a combination of operational expertise, investment experience and board-level perspective to healthcare innovation. Her work spans digital health, MedTech, artificial intelligence and deep technology, with a focus on translating scientific and technological advances into commercially viable businesses.

Alexandra founded FemTech Capital to address a fundamental disconnect in healthcare: significant unmet clinical needs and scientific opportunities that remain insufficiently understood, supported and funded.

Through FemTech Capital, Alexandra is building a specialist ecosystem connecting founders, scientists, clinicians, operators, industry partners and investors to advance innovation across women’s health, sex-specific medicine and longevity.

Her conviction is simple: better science, stronger companies and more informed capital can transform women’s health.